Medac Gesellschaft Fur Klinische competitive analysis

Explore patent oppositions filed by Medac Gesellschaft Fur Klinische against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 11, 2022
Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAMar 22, 2021
Cabazitaxel And Its Use For Treating CancerAVENTIS PHARMASep 18, 2020
Pharmaceutical Compositions Comprising Nilotinib Or Its SaltNOVARTISJun 23, 2016

Latest PTAB cases involving Medac Gesellschaft Fur Klinische

Discover the latest PTAB cases involving Medac Gesellschaft Fur Klinische, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 16, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Medac Gesellschaft Fur Klinische

IPR2014-01091Jul 1, 2014ANTARES PHARMAMEDAC GESELLSCHAFT FUR KLINISCHETerminated-Settled